Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observer-blind randomized comparison of Fluvirin and Influvac in healthy children
2006-002649-35Phase 4Completed
- Sponsor
- Novartis
- Start
- Sep 2006
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (uv, formaldehyde inactivated) and influenza vaccine in influenza (4 arms), sponsored by Novartis. Primary endpoints: Geometric mean titer at day 29, Geometric mean titer at day 50 and 1 more. Started Sep 2006; status: completed.
02
Drugs
influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (uv, formaldehyde inactivated)influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-002649-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002649-35.